Related Experiment Videos
1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA
J Rubin1, D Biskobing, L Titus
1Department of Medicine, Veterans Affairs Medical Center, Atlanta, Georgia, USA.
The American Journal of the Medical Sciences
|February 1, 1996
Summary
This study reveals that prostaglandin E2 rapidly increases complement 5a receptor (C5aR) mRNA, leading to delayed C5aR expression in U937 cells. This highlights complex transcriptional and posttranscriptional regulation of C5aR in immune responses.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Complement 5a receptor (C5aR) plays a crucial role in monocyte recruitment and immune responses.
- Understanding C5aR expression regulation is vital for modulating immune cell activity.
Purpose of the Study:
- To investigate the molecular mechanisms regulating complement 5a receptor (C5aR) expression in human U937 monoblasts.
- To determine the role of prostaglandin E2, 1,25(OH)2D3, and cycloheximide in C5aR mRNA and protein expression.
Main Methods:
- U937 monoblasts were treated with prostaglandin E2, 1,25(OH)2D3, and cycloheximide.
- C5aR mRNA levels were assessed using molecular techniques.
- C5a binding (functional C5aR) was measured to evaluate receptor expression.
Main Results:
- Prostaglandin E2 rapidly increased C5aR mRNA within 3 hours, followed by a delayed increase in C5a binding.
- 1,25(OH)2D3 and cycloheximide enhanced prostaglandin E2-stimulated C5aR mRNA and binding but did not induce them alone.
- Inhibition of the late C5aR mRNA rise significantly reduced C5a binding, underscoring its importance.
Conclusions:
- C5aR expression is a complex process regulated at both transcriptional and posttranscriptional levels.
- Prostaglandin E2 is a key early regulator of C5aR mRNA, influencing subsequent receptor function.
- Combined treatments modulate C5aR expression, suggesting intricate signaling pathways involved in monocyte immune responses.